NBTX · Nanobiotix S.A.
$42.26
+3.95 (+10.30%)
At close · Aug 17
Market Cap
$1.95B
Shares
50.80M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$38.31
Open$37.40
Day$37.17–38.99
52W close$7.91–55.07
Avg vol 30d131K
Short int99K · 0.2% float · 1.0d
Short vol50%
Last earningsDec 31, 2025
DataDec 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+25%
above
Price vs 50-day avg
+1%
above
RSI (14)
49
neutral
MACD trend
Negative
52-week position
64%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+54%
trailing
YTD return
+66%
this year
Relative strength
+40%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $38 › 200d $31 — 50d above 200d
Institutional flow
Accumulating
+27% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.20% of float · ▲ +17.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
19 holders — near 3-yr high, broad support
Squeeze score
39
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
108%
annualized · 1-yr
Max drawdown
−50%
past year
ATR
6.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+25%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
64%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $38 › 200d $31 — 50d above 200d
Institutional flow
Accumulating
+27% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.20% of float · ▲ +17.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
19 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $8
Now $38 · 64%
Range high $55
vs 200-day avg +25%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NBTX
this stock
Nanobiotix S.A.
|
$1.95B | +65.7% | — | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NBTX | +0.2% | +1.4% | +53.9% | -0.2% | +65.7% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.2% | -3.1% | +40.1% | -4.1% | +51.9% |
Key facts
CIK
1760854
CUSIP
63009J107
13F (30d)
20 filings
20 filers
Visit website
Investor relations